Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”

被引：0
|
作者：
Michele R. Wilson
Matt Wasserman
Taj Jadavji
Maarten Postma
Marie-Claude Breton
Francois Peloquin
Stephanie R. Earnshaw
Cheryl McDade
Heather L. Sings
Raymond Farkouh
机构：
[1] RTI Health Solutions,Departments of Pediatrics, Microbiology, Immunology, and Infectious Diseases, Faculty of Medicine, Cumming School of Medicine
[2] Pfizer Inc.,Department of Pharmacy
[3] University of Calgary,Research Institute of Science in Healthy Aging and healthcaRE (SHARE)
[4] University of Groningen,undefined
[5] University of Groningen,undefined
[6] University Medical Center Groningen (UMCG),undefined
[7] Pfizer Canada Inc.,undefined
[8] Pfizer Inc.,undefined
来源：
Infectious Diseases and Therapy | 2018年 / 7卷
关键词：
Cost-effectiveness; Health economics; Pneumococcal disease; Vaccination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：539 / 543
页数：4
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF INFANT VACCINATION WITH 10 AND 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN THE RUSSIAN FEDERATION
    Rudakova, A., V
    Sidorenko, S.
    Kharit, S. M.
    Uskov, A.
    Lobzin, Y., V
    Shchurov, D. G.
    Topachevskyi, O.
    VALUE IN HEALTH, 2012, 15 (07) : A525 - A525
  • [32] Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”
    Makoto Shiragami
    Akiko Mizukami
    Oscar Leeuwenkamp
    Tomas Mrkvan
    Emmanuelle Delgleize
    Yuichi Kurono
    Satoshi Iwata
    Infectious Diseases and Therapy, 2015, 4 (2) : 235 - 244
  • [33] BUDGET-IMPACT ANALYSIS OF ADDING THE NEW 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION (PHID-CV) TO ROUTINE INFANT VACCINATION IN CANADA
    Ismaila, A. S.
    Pereira, J. A.
    Robson, R. C.
    Talbird, S. E.
    Standaert, B. A.
    Rawson, N. S.
    VALUE IN HEALTH, 2009, 12 (07) : A418 - A418
  • [34] Population-level impact of infant 10-valent pneumococcal conjugate vaccination on adult pneumonia hospitalisations in Finland
    Okasha, Omar
    Rinta-Kokko, Hanna
    Palmu, Arto A.
    Ruokokoski, Esa
    Jokinen, Jukka
    Nuorti, J. Pekka
    THORAX, 2018, 73 (03) : 262 - 269
  • [35] Long-term population impact of infant 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in Finland
    Nuorti, J. Pekka
    Rinta-Kokko, Hanna
    Toropainen, Maija
    Siira, Lotta
    Nohynek, Hanna
    Palmu, Arto A.
    VACCINE, 2022, 40 (41) : 5950 - 5958
  • [36] Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1+1 infant schedule in England: a modelling study
    Choi, Yoon Hong
    Bertran, Marta
    Litt, David J.
    Ladhani, Shamez N.
    Miller, Elizabeth
    LANCET PUBLIC HEALTH, 2024, 9 (09):
  • [37] Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants
    Warren, Sophie
    Barmpouni, Myrto
    Kossyvaki, Vasiliki
    Gourzoulidis, George
    Perdrizet, Johnna
    VACCINES, 2023, 11 (08)
  • [38] Comment on: “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”
    Raymond A. Farkouh
    Cassandra Hall-Murray
    Rogier M. Klok
    Betsy Hilton
    Raul E. Isturiz
    Infectious Diseases and Therapy, 2015, 4 (2) : 227 - 233
  • [39] COST-EFFECTIVENESS OF 2+1 DOSING OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE COMPARED WITH 2+1 DOSING OF 10-VALENT CONJUGATE VACCINE IN PREVENTING PNEUMOCOCCAL DISEASE IN CANADA
    Earnshaw, S.
    McDade, C.
    Zanotti, G.
    Farkouh, R. A.
    Strutton, D.
    VALUE IN HEALTH, 2011, 14 (07) : A275 - A275
  • [40] Comment on: "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children''
    Farkouh, Raymond A.
    Hall-Murray, Cassandra
    Klok, Rogier M.
    Hilton, Betsy
    Isturiz, Raul E.
    INFECTIOUS DISEASES AND THERAPY, 2015, 4 (02) : 227 - 233
12345